Education and Training
S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT
RATIONALE: Learning about the long-term effects of chemoprevention drugs, such as finasteride, in patients with prostate cancer may help doctors plan better treatment and follow-up care.
PURPOSE: This clinical trial is following patients who were diagnosed with prostate cancer while undergoing treatment with either finasteride or a placebo on the Prostate Cancer Prevention Trial (PCPT).
Stanford is currently not accepting patients for this trial.
Intervention(s):
- other: Follow-up
Eligibility
INCLUSION CRITERIA:
- Randomized on PCPT
- Diagnosed with prostate cancer on or before December 31, 2003
DISEASE CHARACTERISTICS:
- Diagnosed by either study site or central pathology review
PATIENT CHARACTERISTICS:
- See inclusion criteria
PRIOR CONCURRENT THERAPY:
- Not Applicable
Ages Eligible for Study
55 Years - 120 Years
Genders Eligible for Study
Male
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Ruth Lira
6507231367
Not Recruiting